79
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis

& ORCID Icon
Pages 7175-7186 | Published online: 15 Sep 2021

References

  • BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
  • GradisharWJ, AndersonBO, BalassanianR, et al. Breast cancer, version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16:310–320. doi:10.6004/jnccn.2018.001229523670
  • WangM, DaiM, WangD, et al. The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway. Cancer Lett. 2021;512:60–72. doi:10.1016/j.canlet.2021.04.02533951538
  • PelayoS, BouaudJ, BlancafortC, et al. Preliminary qualitative and quantitative evaluation of DESIREE, a decision support platform for the management of primary breast cancer patients. AMIA Annual Symposium Proceedings. Vol. 2020; 2020:1012–1021.
  • AgirreX, MeydanC, JiangY, et al. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nat Commun. 2019;10:821. doi:10.1038/s41467-019-08679-z30778059
  • Deva Magendhra RaoAK, PatelK, Korivi JyothirajS, et al. Identification of lncRNAs associated with early-stage breast cancer and their prognostic implications. Mol Oncol. 2019;13:1342–1355. doi:10.1002/1878-0261.1248930959550
  • WangLQ, ZhengYY, ZhouHJ, ZhangXX, WuP, ZhuSM. LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microglia. Mol Med. 2021;27:39. doi:10.1186/s10020-021-00299-y33858325
  • DaiJ, ZhangS, SunH, WuY, YanM. LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis. Biochem Biophys Res Commun. 2021;560:119–125. doi:10.1016/j.bbrc.2021.04.13333989902
  • NingX, ZhaoJ, HeF, YuanY, LiB, RuanJ. Long non-coding RNA TMPO-AS1 facilitates chemoresistance and invasion in breast cancer by modulating the miR-1179/TRIM37 axis. Oncol Lett. 2021;22:500. doi:10.3892/ol.2021.1276133981362
  • HuangJ, XieY, SunX, et al. DAMPs, ageing, and cancer: the ‘DAMP Hypothesis’. Ageing Res Rev. 2015;24:3–16. doi:10.1016/j.arr.2014.10.00425446804
  • BergsbakenT, FinkSL, CooksonBT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99–109. doi:10.1038/nrmicro207019148178
  • TanC, LiuW, ZhengZH, WanXG. LncRNA HOTTIP inhibits cell pyroptosis by targeting miR-148a-3p/AKT2 axis in ovarian cancer. Cell Biol Int. 2021;45(7):1487–1497. doi:10.1002/cbin.1158833710684
  • RenN, JiangT, WangC, et al. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. Aging (Albany NY). 2020;12:11025–11041. doi:10.18632/aging.10331432516127
  • XuX, ZhouX, ChenZ, GaoC, ZhaoL, CuiY. Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin. Aging (Albany NY). 2020;12(6):4711–4726. doi:10.18632/aging.10267332209729
  • DengJ, TanW, LuoQ, LinL, ZhengL, YangJ. Long non-coding RNA MEG3 promotes renal tubular epithelial cell pyroptosis by regulating the miR-18a-3p/GSDMD pathway in lipopolysaccharide-induced acute kidney injury. Front Physiol. 2021;12:663216. doi:10.3389/fphys.2021.66321634012408
  • KarkiR, KannegantiTD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19:197–214. doi:10.1038/s41568-019-0123-y30842595
  • XiaX, WangX, ChengZ, et al. The role of pyroptosis in cancer: pro-cancer or pro-”host”?Cell Death Dis. 2019;10:650. doi:10.1038/s41419-019-1883-831501419
  • WangB, YinQ. AIM2 inflammasome activation and regulation: a structural perspective. J Struct Biol. 2017;200:279–282. doi:10.1016/j.jsb.2017.08.00128813641
  • ManSM, KannegantiTD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21. doi:10.1111/imr.1229625879280
  • KareemSH, NajiAM, TaqiZJ, JabirMS. Polyvinylpyrrolidone loaded-MnZnFe 2 O 4 magnetic nanocomposites induce apoptosis in cancer cells through mitochondrial damage and P 53 pathway. J Inorg Organomet Polym Mater. 2020;30(12):5009–5023. doi:10.1007/s10904-020-01651-1
  • SiegelRL, MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.2155130620402
  • LiangY, ZhangH, SongX, YangQ. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14–27. doi:10.1016/j.semcancer.2019.08.01231421262
  • FangY, TianS, PanY, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121:109595. doi:10.1016/j.biopha.2019.10959531710896
  • WuJ, ZhuP, LuT, et al. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling. J Hepatol. 2019;70:918–929. doi:10.1016/j.jhep.2018.12.01530582981
  • ZhangL, YaoHR, LiuSK, SongLL. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer. Eur Rev Med Pharmacol Sci. 2020;24:2928–2937. doi:10.26355/eurrev_202003_2065632271410
  • QiC, XiaofengC, DongenL, et al. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway. J Exp Clin Cancer Res. 2019;38:344. doi:10.1186/s13046-019-1332-731391063
  • ZhongC, YuQ, PengY, et al. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma. J Exp Clin Cancer Res. 2021;40:123. doi:10.1186/s13046-021-01928-433832517
  • ZhangY, LiuX, BaiX, et al. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 2018;64(2):e12449. doi:10.1111/jpi.12449
  • WuQ, LiQ, ZhuW, ZhangX, LiH. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer. J Cell Mol Med. 2021;25:4088–4098. doi:10.1111/jcmm.1637833694315
  • YaoR, ChenY, HaoH, et al. Pathogenic effects of inhibition of mTORC1/STAT3 axis facilitates Staphylococcus aureus-induced pyroptosis in human macrophages. Cell Commun Signal. 2020;18:187. doi:10.1186/s12964-020-00677-933256738
  • VasiliouSK, DiamandisEP. Androgen receptor: a promising therapeutic target in breast cancer. Crit Rev Clin Lab Sci. 2019;56:200–223. doi:10.1080/10408363.2019.157564330821186
  • FengJ, LiL, ZhangN, et al. Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. Oncogene. 2017;36:2775–2790. doi:10.1038/onc.2016.43227893717
  • de HeerEC, JalvingM, HarrisAL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130:5074–5087. doi:10.1172/jci13755232870818
  • TangX, ShiL, XieN, et al. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis. Nat Commun. 2017;8:318. doi:10.1038/s41467-017-00396-928827661
  • HareSH, HarveyAJ. mTOR function and therapeutic targeting in breast cancer. Am J Cancer Res. 2017;7:383–404.28400999
  • SulaimanA, McGarryS, LamKM, et al. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. Cell Death Dis. 2018;9:815. doi:10.1038/s41419-018-0811-730050079
  • BaruchEN, WangJ, WargoJA. Gut microbiota and antitumor immunity: potential mechanisms for clinical effect. Cancer Immunol Res. 2021;9:365–370. doi:10.1158/2326-6066.Cir-20-087734003768